
Sign up to save your podcasts
Or
Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer.
CME information and select publications here
4.4
3030 ratings
Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer.
CME information and select publications here
17 Listeners
15 Listeners
63 Listeners
12 Listeners
73 Listeners
0 Listeners
6 Listeners
316 Listeners
42 Listeners
110 Listeners
54 Listeners
124 Listeners
43 Listeners
27 Listeners
54 Listeners
84 Listeners
166 Listeners